ECSP055581A - "CICLOBUTEN-1,2-DIONAS 3,4-DI-SUBSTITUTED AS LIGANDS OF THE CXC CHEMIOKIN RECEPTOR" - Google Patents

"CICLOBUTEN-1,2-DIONAS 3,4-DI-SUBSTITUTED AS LIGANDS OF THE CXC CHEMIOKIN RECEPTOR"

Info

Publication number
ECSP055581A
ECSP055581A EC2005005581A ECSP055581A ECSP055581A EC SP055581 A ECSP055581 A EC SP055581A EC 2005005581 A EC2005005581 A EC 2005005581A EC SP055581 A ECSP055581 A EC SP055581A EC SP055581 A ECSP055581 A EC SP055581A
Authority
EC
Ecuador
Prior art keywords
ciclobuten
chemiokin
dionas
cxc
ligands
Prior art date
Application number
EC2005005581A
Other languages
Spanish (es)
Inventor
Arthur G Taveras
Cynthia J Aki
Jianping Chao
Michael Dwyer
Jianhua Chao
Younong Yu
J Robert Merritt
Purakkattle Biju
James Jakway
Gaifa Lai
Minglang Wu
Evan A Hecker
Daniel Lundell
Jay S Fine
Original Assignee
Schering Corp
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/208,412 external-priority patent/US20040097547A1/en
Priority claimed from US10/241,326 external-priority patent/US20040106794A1/en
Application filed by Schering Corp, Pharmacopeia Inc filed Critical Schering Corp
Publication of ECSP055581A publication Critical patent/ECSP055581A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Se revelan nuevos compuestos de la fórmula:ó una sal ó solvato farmacéuticamente aceptable de los mismos. Además se revela el tratamiento de las enfermedades mediadas por quimiocina utilizando los compuestos de la fórmula:New compounds of the formula are revealed: or a pharmaceutically acceptable salt or solvate thereof. In addition, treatment of chemokine-mediated diseases using the compounds of the formula is revealed:

EC2005005581A 2002-07-30 2005-01-27 "CICLOBUTEN-1,2-DIONAS 3,4-DI-SUBSTITUTED AS LIGANDS OF THE CXC CHEMIOKIN RECEPTOR" ECSP055581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/208,412 US20040097547A1 (en) 2001-04-16 2002-07-30 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
US10/241,326 US20040106794A1 (en) 2001-04-16 2002-09-11 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Publications (1)

Publication Number Publication Date
ECSP055581A true ECSP055581A (en) 2005-04-18

Family

ID=35912828

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005581A ECSP055581A (en) 2002-07-30 2005-01-27 "CICLOBUTEN-1,2-DIONAS 3,4-DI-SUBSTITUTED AS LIGANDS OF THE CXC CHEMIOKIN RECEPTOR"

Country Status (8)

Country Link
JP (1) JP2011063591A (en)
CN (1) CN100338032C (en)
AR (1) AR040734A1 (en)
CO (1) CO5680474A2 (en)
EC (1) ECSP055581A (en)
PE (1) PE20040746A1 (en)
TW (1) TWI330174B (en)
ZA (1) ZA200500837B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1334797A (en) * 1998-12-14 2002-02-06 美国家用产品公司 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4
HUP0302382A3 (en) * 2000-05-30 2004-09-28 Smithkline Beecham Corp Il-8 receptor antagonists and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AR040734A1 (en) 2005-04-20
PE20040746A1 (en) 2004-10-23
JP2011063591A (en) 2011-03-31
CN1723194A (en) 2006-01-18
CN100338032C (en) 2007-09-19
TW200410920A (en) 2004-07-01
TWI330174B (en) 2010-09-11
CO5680474A2 (en) 2006-09-29
ZA200500837B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
BR0313109A (en) Cyclobutene-1,2-diones 3,4-disubstituted as cxc chemokine receptor ligands
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
UY28132A1 (en) PIRROLOPIRIMIDINE DERIVATIVES
DOP2002000456A (en) INHIBITORS OF THE ALQUIN-ARIL FOSFODIESTERASA-4 ''
ECSP055684A (en) OPIODE RECEIVER ANTAGONISTS
NO20052512L (en) Purine compounds and use deav as cannabinoid receptor ligands
RU2325389C2 (en) Composition and derivatives of substituted azaindoloxoacetapiperazine characterized by antiviral activity
ECSP066313A (en) DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS
ECSP066315A (en) DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS
SE0200979D0 (en) New compounds
CR7510A (en) DERIVATIVES OF [1-4] DIAZEPINO [6,7,1-iJ)] QUINOLONA AS ANTIPSYTIC AGENTS AND AGAINST OBESITY
ECSP066312A (en) PIRIDILO DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
UY28885A1 (en) 4-PHENYLAMINE-QUINAZOLIN-6-IL-AMIDAS CROSSED REFERENCE ON RELATED APPLICATION (S)
NO20060971L (en) Pyridazine derivatives and their use as therapeutic agents
BRPI0418939A (en) nicotinamide derivatives and their use as therapeutic agents
UY27939A1 (en) COMPOUNDS
PA8514401A1 (en) NEW DERIVATIVES OF PIPERAZINA
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
ATE344033T1 (en) VINYLPHENYL DERIVATIVES AS GLK ACTIVATORS
SE0102300D0 (en) Compounds
ECSP066493A (en) SYNERGIC COMBINATIONS OF ACTIVE PRODUCTS, FUNGICIDES
ES2156287T3 (en) DERIVATIVES OF DIFENILMETILEN PIPERIDINA.
UY27481A1 (en) ALKINS AS MATRIX METALOPROTEINASE INHIBITORS
EA200801909A1 (en) PYRIDINE COMPOUNDS FOR THE TREATMENT OF DISEASES MEDIATED BY PROSTAGLANDINE
ATE364605T1 (en) 3-ARYLOXY AND 3-HETEROARYLOXY SUBSTITUTED BENZO(B) THIOPHENES AS THERAPEUTIC ACTIVES WITH PI3K ACTIVITY